• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估动静脉畸形、脑膜瘤、听神经瘤和视交叉的 α/β 比值。

Assessment of the alpha/beta ratios for arteriovenous malformations, meningiomas, acoustic neuromas, and the optic chiasma.

机构信息

Department of Radiation Oncology, Tygerberg Hospital, Tygerberg, South Africa.

出版信息

Int J Radiat Biol. 2010 Jun;86(6):486-98. doi: 10.3109/09553001003667982.

DOI:10.3109/09553001003667982
PMID:20470198
Abstract

PURPOSE

To determine alpha/beta (alpha/beta) values of arteriovenous malformations (AVM), meningiomas, acoustic neuromas (AN), and the optic chiasma using clinical data.

METHODS AND MATERIALS

Data of dose/fractionation schedules form the literature, iso-effective for a specific clinical outcome, were analysed using the Fraction Equivalent plot (FE) method and the Tucker method. Established safe dose/fractionation schedules for the optic chiasma were used to determine its alpha/beta value.

RESULTS

With the FE plot method, an alpha/beta value of 3.76 Gray (Gy) (95% confidence level [CL]: 2.8-4.6 Gy) for meningiomas, 2.4 Gy (95% CL: 0.8-3.9 Gy) for acoustic neuroma, and 14.7 Gy (95% CL: 3.8-25.7 Gy) for arteriovenous malformations were determined. The respective alpha/beta values using the Tucker method were 3.3 Gy (95%CL: 2.2-6.8 Gy), 1.77 Gy (95%CL: 1.3-3.0 Gy) and -57 Gy (95%CL: -79.6 to -35.2 Gy). No meaningful alpha/beta values could be determined for the optic chiasma.

CONCLUSION

Acoustic neuromas with a low alpha/beta value would show no lesion intrinsic benefit from fractionation. Meningiomas probably benefit from a hypofractionated schedule. The high alpha/beta value for AVM can be explained but needs further research. Fractionation versus radiosurgery can be considered when the primary objective is to avoid normal tissue damage.

摘要

目的

利用临床数据确定动静脉畸形(AVM)、脑膜瘤、听神经瘤(AN)和视交叉的α/β值。

方法和材料

使用 Fraction Equivalent plot(FE)方法和 Tucker 方法分析了文献中剂量/分割方案的数据,这些数据对于特定的临床结果具有等效性。使用视交叉的既定安全剂量/分割方案来确定其α/β值。

结果

通过 FE 图方法,确定脑膜瘤的α/β值为 3.76 戈瑞(Gy)(95%置信区间[CL]:2.8-4.6 Gy),听神经瘤为 2.4 Gy(95%CL:0.8-3.9 Gy),动静脉畸形为 14.7 Gy(95%CL:3.8-25.7 Gy)。使用 Tucker 方法分别确定的α/β值为 3.3 Gy(95%CL:2.2-6.8 Gy)、1.77 Gy(95%CL:1.3-3.0 Gy)和-57 Gy(95%CL:-79.6 至-35.2 Gy)。对视交叉无法确定有意义的α/β值。

结论

具有低α/β值的听神经瘤不会从分割中获得病灶内在获益。脑膜瘤可能受益于低分割方案。AVM 的高α/β值可以解释,但需要进一步研究。当主要目标是避免正常组织损伤时,可以考虑分割与放射外科治疗。

相似文献

1
Assessment of the alpha/beta ratios for arteriovenous malformations, meningiomas, acoustic neuromas, and the optic chiasma.评估动静脉畸形、脑膜瘤、听神经瘤和视交叉的 α/β 比值。
Int J Radiat Biol. 2010 Jun;86(6):486-98. doi: 10.3109/09553001003667982.
2
Alpha/beta ratio for arteriovenous malformations estimated from obliteration rates after fractionated and single-dose irradiation.根据分次照射和单次照射后的闭塞率估算的动静脉畸形的α/β比值。
Radiother Oncol. 2004 Apr;71(1):109-14. doi: 10.1016/j.radonc.2003.08.005.
3
Conventional fractionated radiation therapy vs. radiosurgery for selected benign intracranial lesions (arteriovenous malformations, pituitary adenomas, and acoustic neuromas).常规分割放射治疗与立体定向放射外科治疗特定良性颅内病变(动静脉畸形、垂体腺瘤和听神经瘤)的比较
J Neurooncol. 1993 Sep;17(3):223-30. doi: 10.1007/BF01049978.
4
Benign brain tumors. Meningiomas, pituitary tumors, and acoustic neuromas.良性脑肿瘤。脑膜瘤、垂体瘤和听神经瘤。
Neurol Clin. 1995 Nov;13(4):927-52.
5
Adverse radiation effects after Gamma Knife Surgery in relation to dose and volume.伽玛刀手术后与剂量和体积相关的辐射不良反应
Acta Neurochir (Wien). 2009 Jan;151(1):9-19. doi: 10.1007/s00701-008-0174-4. Epub 2009 Jan 8.
6
Direct costs of microsurgical management of radiosurgically amenable intracranial pathology in Germany: an analysis of meningiomas, acoustic neuromas, metastases and arteriovenous malformations of less than 3 cm in diameter.德国对颅内可采用放射外科治疗的病变进行显微外科治疗的直接成本:对直径小于3厘米的脑膜瘤、听神经瘤、转移瘤和动静脉畸形的分析。
Acta Neurochir (Wien). 2003 Apr;145(4):249-55. doi: 10.1007/s00701-003-0007-4.
7
Optimization of stereotactic radiotherapy treatment delivery technique for base-of-skull meningiomas.颅底脑膜瘤立体定向放射治疗技术的优化
Med Dosim. 2008 Autumn;33(3):239-47. doi: 10.1016/j.meddos.2008.03.003. Epub 2008 Apr 28.
8
Moderately low alpha/beta ratio for rectal cancer may best explain the outcome of three fractionation schedules of preoperative radiotherapy.直肠癌相对较低的α/β比值或许能最好地解释术前放疗三种分割方案的结果。
Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):793-9. doi: 10.1016/j.ijrobp.2007.03.046. Epub 2007 May 17.
9
Tomotherapy planning of small brain tumours.小脑肿瘤的螺旋断层放射治疗计划
Radiother Oncol. 2005 Jan;74(1):49-52. doi: 10.1016/j.radonc.2004.10.017.
10
Spot-scanning proton radiation therapy for recurrent, residual or untreated intracranial meningiomas.适形调强质子放疗用于复发性、残留性或未经治疗的颅内脑膜瘤。
Radiother Oncol. 2004 Jun;71(3):251-8. doi: 10.1016/j.radonc.2004.02.011.

引用本文的文献

1
The Effects of Radiation Therapy on the Ocular Apparatus: Implications for Management.放射治疗对眼部器官的影响:管理启示
Cancers (Basel). 2025 Aug 8;17(16):2605. doi: 10.3390/cancers17162605.
2
Management of treatment-naïve Koos grade IV vestibular schwannomas using hypofractionated Gamma Knife radiosurgery: a retrospective single-institution study.采用分次伽玛刀放射外科治疗初治 Koos 分级 IV 型前庭神经鞘瘤:回顾性单中心研究。
Neurosurg Rev. 2024 Nov 26;47(1):874. doi: 10.1007/s10143-024-03125-1.
3
Robotic Stereotactic Radiotherapy for Intracranial Meningiomas-An Opportunity for Radiation Dose De-Escalation.
颅内脑膜瘤的机器人立体定向放射治疗——降低辐射剂量的契机
Cancers (Basel). 2023 Nov 16;15(22):5436. doi: 10.3390/cancers15225436.
4
Can Apparent Diffusion Coefficient (ADC) maps replace Diffusion Tensor Imaging (DTI) maps to predict the volumetric response of meningiomas to Gamma Knife Radiosurgery?表观扩散系数(ADC)图能否替代弥散张量成像(DTI)图来预测脑膜瘤对伽玛刀放射外科的体积反应?
J Neurooncol. 2023 Feb;161(3):547-554. doi: 10.1007/s11060-023-04243-4. Epub 2023 Feb 6.
5
Dose-response relationship in patients with newly diagnosed atypical meningioma treated with adjuvant radiotherapy.新诊断的非典型脑膜瘤患者接受辅助放疗的剂量反应关系。
J Neurooncol. 2023 Jan;161(2):329-337. doi: 10.1007/s11060-022-04206-1. Epub 2022 Dec 5.
6
The "Combo" radiotherapy treatment for high-risk grade 2 meningiomas: dose escalation and initial safety and efficacy analysis.“Combo”放疗治疗高危 2 级脑膜瘤:剂量递增及初步安全性和疗效分析。
J Neurooncol. 2023 Jan;161(2):203-214. doi: 10.1007/s11060-022-04107-3. Epub 2022 Aug 4.
7
MRI radiomics in the prediction of the volumetric response in meningiomas after gamma knife radiosurgery.磁共振影像组学预测伽玛刀放射外科治疗脑膜瘤后的体积变化。
J Neurooncol. 2022 Sep;159(2):281-291. doi: 10.1007/s11060-022-04063-y. Epub 2022 Jun 17.
8
Multisession radiosurgery for grade 2 (WHO), high risk meningiomas. A phase II clinical trial.分次立体定向放射外科治疗 2 级(WHO)、高危脑膜瘤。一项 II 期临床试验。
J Neurooncol. 2022 May;157(3):397-403. doi: 10.1007/s11060-022-03978-w. Epub 2022 Apr 4.
9
Stereotactic Radiosurgery for Perioptic Meningiomas: An International, Multicenter Study.立体定向放射外科治疗眶周脑膜瘤:一项国际多中心研究。
Neurosurgery. 2021 Mar 15;88(4):828-837. doi: 10.1093/neuros/nyaa544.
10
Moderately Hypofractionated Radiation for Benign Meningiomas and Schwannomas: A Report of 70 Patients Treated Between 2008 and 2018.良性脑膜瘤和神经鞘瘤的适度低分割放疗:2008年至2018年期间治疗的70例患者报告
Adv Radiat Oncol. 2020 Sep 28;5(6):1147-1151. doi: 10.1016/j.adro.2020.09.009. eCollection 2020 Nov-Dec.